Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia
Neuropsychiatric Disease and Treatment · 2026-05 · Volume 22 · 1-14
DOI: 10.2147/ndt.s603001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropsychiatric Disease and Treatment, 2026-05. Verfasst von WanHeng Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Peking University Sixth Hospital, Beijing, People's Republic of China. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Peking University Sixth Hospital, Beijing, People's Republic of China.
- Department of Psychiatry, Peking University Institute of Mental Health, Beijing, People's Republic of China.
- NHC Key Laboratory of Mental Health, Peking University, Beijing, People's Republic of China.
- National Clinical Research Centre for Mental Disorders, Peking University Sixth Hospital, Beijing, People's Republic of China.
ORCID-Profile: WanHeng Hu, Xin Yu
Zitieren
APA
Hu, W., Huang, B., Guo, X., Yin, X., Wang, X., Ji, Y., Zheng, Y., Gao, T., Shi, C., Yu, X., & Pu, C. (2026). Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia. Neuropsychiatric Disease and Treatment, Volume 22, 1-14. https://doi.org/10.2147/ndt.s603001
Vancouver
Hu W, Huang B, Guo X, Yin X, Wang X, Ji Y, et al. Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia. Neuropsychiatric Disease and Treatment. 2026;Volume 22:1-14. doi:10.2147/ndt.s603001
BibTeX
@article{Hu2026,
author = {Hu, WanHeng and Huang, BingJie and Guo, XiaoDong and Yin, XiaoLin and Wang, XiangHe and Ji, YunFei and Zheng, Yue and Gao, TianQi and Shi, Chuan and Yu, Xin and Pu, Chengcheng},
title = {Comparison of Neurocognitive Effects of Blonanserin, Olanzapine, Aripiprazole, and Risperidone in Drug-Naïve First-Episode Schizophrenia},
journal = {Neuropsychiatric Disease and Treatment},
year = {2026},
volume = {Volume 22},
pages = {1--14},
doi = {10.2147/ndt.s603001}
}
EUVIMED